This webinar will explore current treatment options for patients with muscle-invasive urothelial carcinoma. Faculty will discuss the patient treatment journey and how they are incorporating immunotherapy in earlier stages of bladder cancer as well as share perspectives of patient and healthcare providers on novel endpoints such as disease free survival and quality of life. The discussion will be illustrated with clinical data and faculty clinical experience.
We will be joined by:
Guillermo De Velasco, MD, PhD
Medical Oncologist
University Hospital 12 de Octubre
Madrid, Spain
Srikala Sridhar, MD, MSc, FRCPC
Professor Medical Oncologist
Princess Margaret Cancer Centre
Toronto, Canada
This webinar is sponsored by BMS.
